论文部分内容阅读
Curcumin (Cur) is a naturally derived, novel anti-inflammatory agent, but its poor syringeabilitylimits its clinical use.The aim of the present study is to encapsulate Cur into solidlipid nanoparticles (SLNs) to improve its syringeability and anti-inflammatory activity.